Tau Therapeutics LLC, a development stage biopharmaceutical company, focuses on the research, development, repositioning, and commercialization of calcium T-channel therapy agents as cytostatic anti-cancer drugs. It offers calcium T-channel blockers for oncology and other diseases. The company was founded in 2003 and is based in Charlottesville, Virginia.